EUVIMEDOpdag EUVIMED
Crossref

T cell vaccine against MRL-lpr/lpr mice

Yuko Nate Williams, Megumi Matsuda, Keiko Ochiai, Ryuji Nagata, Toyozo Sekiguchi, Hiroaki Yamamoto, Minoru Kohno

Japanese Journal of Rheumatology · 1998

DOI: 10.1007/bf03041248 ↗

At a glance

Journal article in Japanese Journal of Rheumatology, 1998. Written by Yuko Nate Williams and 6 co-authors. Cited 1 times so far (Crossref); 34 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

T cell vaccine has been reported as being capable of regulating auto-reactive T cells in experimental autoimmune disease in mice and rats. In this paper we discuss the correction of auto-immunity in spontaneous autoimmune mice, MRL- lpr/lpr mice. Lymph node lymphocytes of young lpr mice were cultured in an anti-CD3 mAb immobilized dish in a medium containing recombinant interleukin-2, concanavalin A and ZnSO 4 for a total of 7 days. These cells were then fixed and used as the T cell vaccine. The effects of this T cell vaccine were examined as: (i) lymphadenopathy by enumeration of lymph node lymphocytes; (ii) gross observation and histopathological examination of dermal lesions; (iii) measurement of the serum titer of the autoantibodies; and (iv) T cell subset analysis of lymph node lymphocytes by FACS. We found: (i) a decrease of lymphadenopathy (about one-third the value of the control); (ii) a marked delay in the onset of dermal lesions; (iii) a lowering of the serum titer of anti-double-stranded DNA antibody; and (iv) a decrease in the percentage of Thy-1.2 + /B220 + T cells, accompanied by an increase in the percentage of Thy-1.2 + /B220 − T cells, in the T cell vaccinated mice. We conclude that T cell vaccine in its present form is partially effective in the correction of disease and abnormal T cell subsets in lpr mice. This treatment may also be feasible for the immunotherapy of human autoimmune diseases.

Cite

APA

Williams, Y. N., Matsuda, M., Ochiai, K., Nagata, R., Sekiguchi, T., Yamamoto, H., & Kohno, M. (1998). T cell vaccine against MRL-lpr/lpr mice. Japanese Journal of Rheumatology. https://doi.org/10.1007/bf03041248

Vancouver

Williams YN, Matsuda M, Ochiai K, Nagata R, Sekiguchi T, Yamamoto H, et al. T cell vaccine against MRL-lpr/lpr mice. Japanese Journal of Rheumatology. 1998. doi:10.1007/bf03041248

BibTeX
@article{Williams1998,
  author = {Williams, Yuko Nate and Matsuda, Megumi and Ochiai, Keiko and Nagata, Ryuji and Sekiguchi, Toyozo and Yamamoto, Hiroaki and Kohno, Minoru},
  title = {T cell vaccine against MRL-lpr/lpr mice},
  journal = {Japanese Journal of Rheumatology},
  year = {1998},
  doi = {10.1007/bf03041248}
}
Start for free →